Company Description
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally.
It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets.
It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors.
American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
| Country | United States |
| Founded | 1969 |
| Industry | Agricultural Inputs |
| Sector | Materials |
| Employees | 845 |
| CEO | Timothy Donnelly |
Contact Details
Address: 4695 MacArthur Court Newport Beach, California 92660 United States | |
| Phone | 949 260 1200 |
| Website | american-vanguard.com |
Stock Details
| Ticker Symbol | AVD |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000005981 |
| CUSIP Number | 030371108 |
| ISIN Number | US0303711081 |
| Employer ID | 95-2588080 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Timothy J. Donnelly Esq. | Acting Chief Executive Officer, General Counsel, Chief Administrative Officer and Secretary |
| David T. Johnson C.F.A. | Vice President, Chief Financial Officer and Treasurer |
| Peter E. Eilers | Managing Director of AMVAC Netherlands BV |
| Andrew B. Naughton | Vice President and Director of Technology |
| William A. Kuser | Director of Investor Relations and Corporate Communications |
| Shirin Khosravi | Senior Vice President of Human Resources |
| Donald J. Gualdoni | Chief Transformation Officer |
| Robert F. Gilbane | President of Gemchem Inc |
| James Thompson | Director of Business Development, Portfolio Management Biologicals and Non-Crop |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 31, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Aug 29, 2024 | 144 | Filing |
| Aug 29, 2024 | 144 | Filing |
| Aug 23, 2024 | 8-K | Current Report |
| Aug 9, 2024 | 8-K | Current Report |
| Aug 9, 2024 | 10-Q | Quarterly Report |
| Jul 17, 2024 | 8-K | Current Report |